Baxter Survey Data, Baxter Healthcare Corp., Deerfield. IL, U.S.A. 1994.
2.
HortonM.W., DeeterRa., ShermanR.A.Treatment of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.Clin Pharm1990; 9: 102–18.
3.
The Ad Hoc Advisory Committee on Peritonitis Management.Peritoneal dialysis-related peritonitis treatment recommendations 1993 update.Perit Dial Int1993; 13: 14–28.
4.
BailieaR, EiseleaContinuous ambulatory peritoneal dialysis: a review of its mechanics, advantages, complications, and areas of controversy.Ann Pharmacother1992; 261: 1409–20.
5.
SaklayenMaCAPD peritonitis: incidence. pathogens, diagnosis and management.Med Clin North Am1990; 74: 997–1010.
6.
PetersonP.K., Matzkea, KeaneW.F.Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis.Rev Infect Dis1987; 9: 604–12.
7.
PirainoB., BernardiniJ., HolleyJ.L.A comparison of peritoneal dialysis-related infections in short and long-term peritoneal dialysis patients.Perit Dial Int1993; 13: 194–7.
8.
ProwantB.Nolph K, Ryan L, et al. Peritonitis in continuous ambulatory peritoneal dialysis: analysis of an 8 year experience.Nephron1986; 43: 105–9.
9.
ChanM.K., ChauP.Y., ChanW.W.Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin.J Antimicrob Chemother1988; 22: 371–5.
10.
ChanM.K., CheungI.K., NgW.S.A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis1990; 15: 155–9.
11.
ChengI.K., ChanC.Y., WongW.T.A randomized prospective comparison of oral ofloxacin and intraperitoneal vancomycin plus aztreonam in the treatment of bacterial peritonitis complicating continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Int1991; II: 2730.
12.
KampfD., BornerK., HainH.Multiple-dosekinetics of ofloxacin after intraperitoneal application in CAPD patients.Perit Dial Int1991; 11: 317–21.
13.
FlorS.Pharmacokinetics of ofloxacin -an overview.Am J Med1990; 87(Suppl 6C): 24S–30S.
14.
ToddP.A., FauldsD.Ofloxacin: a reappraisal of its antimicrobial activity, pharmacology and therapeutic use.Drugs1991; 42: 825–76.
